Gordon Feinblatt specializes in helping hi-tech and biotech companies realize their commercial and IP potential, from capital formation to licensing and exit strategies, working with emerging to global companies, as well as venture capital investors.

With almost 2 decades of experience working with Fortune 500 technology companies in the United States, Europe, Japan, Korea, Taiwan and China, we have a network and reputation for integrity that is unsurpassed in the industry.